Skip to content

The study of efficacy of CMT and their mechanism of Cerebral metabolism

The study of efficacy of CMT and their mechanism of Cerebral metabolism

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053015
Enrollment
Unknown
Registered
2021-11-09
Start date
2014-01-01
Completion date
Unknown
Last updated
2023-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer

Interventions

Individual Story version CMT group:Individual Story version CMT
Individual Game version CMT group:Individual Game version CMT
Group Story version CMT group:Group Story version CMT
Group Game version CMT group:Group Game version CMT

Sponsors

The First Affiliated Hospital of Guangdong Pharmaceutical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinically diagnosed as T3 stage lung cancer with pathological diagnosis; 2. The condition is stable after standard treatment; 3. The average standard total score of the Self-rating Anxiety Scale (SAS) is >= 50, and the self-rating Depression Scale (SDS) index is >= 0.5; 4. Aged 25-60 years, junior high school education or above; 5. Patients voluntarily participate in the research and sign an informed consent form; 6. No need for hospitalization in the past month and the estimated month in the future; 7. The home address is in Guangzhou.

Exclusion criteria

Exclusion criteria: 1. Patients with mental illness; 2. Patients with other physical diseases; 3. With severe substance abuse; 4. Patients who are unable to undergo psychotherapy; 5. Women during pregnancy or breastfeeding.

Design outcomes

Primary

MeasureTime frame
Mental index;Brain waves;Immune index;Magnetic Resonance Spectrum;

Secondary

MeasureTime frame
Blood pressure;Heart rate;Respiratory rate;Galvanic skin response;Skin temperature;

Countries

China

Contacts

Public ContactHuang Xuewei

The First Affiliated Hospital of Guangdong Pharmaceutical University

786991828@qq.com+86 20 34055866

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026